Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases-Reference-Cited by-同舟云学术

Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases

Published:2019-06-14 Issue:8 Volume:15 Page:837-848
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Papamichael Konstantinos¹,Vogelzang Erik H.²,Lambert Jo³,Wolbink Gertjan²⁴,Cheifetz Adam S.¹

Affiliation:

1. Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

2. Rheumatology and Immunology Center, Research by AMC, READE and VUMC, Amsterdam, the Netherlands

3. Department of Dermatology, Ghent University, Ghent, Belgium

4. Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Center, Amsterdam, the Netherlands

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2019.1630273

Reference123 articles.

1. Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

2. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis?

3. Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment

4. Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

5. Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation;The AAPS Journal;2024-07-24

2. Saffron as a Promising Therapy for Inflammatory Bowel Disease;Nutrients;2024-07-20

3. Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study;JEADV Clinical Practice;2024-07-04

4. Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis;Journal of the European Academy of Dermatology and Venereology;2024-05-08

5. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05